Publicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen del Rocío (79)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

2022

  1. Adverse events: an expensive and avoidable hospital problem

    Annals of Medicine, Vol. 54, Núm. 1, pp. 3157-3168

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Prevalence, characteristics, and impact of adverse events in 34 Madrid hospitals. The ESHMAD study

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

2021

  1. Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  2. Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2

    Cell Death and Disease, Vol. 12, Núm. 6

  3. The Study on Safety in Hospitals in the Region of Madrid (ESHMAD) design: Screening and analysis of incidents and adverse events

    Journal of Healthcare Quality Research, Vol. 36, Núm. 4, pp. 231-239

2020

  1. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

    Molecular Cancer, Vol. 19, Núm. 1

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2018

  1. NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through sirt1 and PARP

    Clinical Cancer Research, Vol. 24, Núm. 5, pp. 1202-1215

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain

    AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

  4. Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus

    Oncotarget, Vol. 8, Núm. 35, pp. 58872-58886

  5. NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis

    Oncotarget, Vol. 8, Núm. 59, pp. 99514-99530

  6. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  2. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5